Process development for production of pharmaceutical grade plasmid DNA to be used in gene therapy and DNA vaccination

被引:0
|
作者
Lueer, C. [1 ]
Bohle, K. [1 ]
Ross, A. [1 ]
Ziehr, H. [1 ]
机构
[1] Fraunhofer ITEM, Pharmaceut Biotechnol, D-38124 Braunschweig, Germany
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:A74 / A74
页数:1
相关论文
共 50 条
  • [31] Preparation of pharmaceutical-grade plasmid DNA using methacrylate monolithic columns
    Smrekar, Franc
    Podgornik, Ales
    Ciringer, Mateja
    Kontrec, Sandra
    Raspor, Peter
    Strancar, Ales
    Peterka, Matjaz
    VACCINE, 2010, 28 (08) : 2039 - 2045
  • [32] Purification of pharmaceutical-grade plasmid DNA by anion-exchange chromatography in an RNase-free process
    Eon-Duval, A
    Burke, G
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 804 (02): : 327 - 335
  • [33] Plasmid DNA production
    Santos, JAL
    Freitas, SS
    Prazeres, DMF
    JOURNAL OF BIOTECHNOLOGY, 2005, 118 : S73 - S73
  • [34] Large scale purification of plasmid DNA for gene therapy
    Stadler, J
    CANCER GENE THERAPY, 1997, 4 (05) : 328 - 328
  • [35] Effects of medium composition on the production of plasmid DNA vector potentially for human gene therapy
    徐志南
    沈文和
    陈灏
    岑沛霖
    Journal of Zhejiang University Science, 2005, (05) : 396 - 400
  • [36] Effects of medium composition on the production of plasmid DNA vector potentially for human gene therapy
    Xu Z.-N.
    Shen W.-H.
    Chen H.
    Cen P.-L.
    Journal of Zhejiang University-SCIENCE B, 2005, 6 (5): : 396 - 400
  • [37] Plasmid DNA Nanoparticles for Nonviral Oral Gene Therapy
    Shahriar, S. M. Shatil
    An, Jeong Man
    Hasan, Mohammad Nazmul
    Surwase, Sachin S.
    Kim, Yeu-Chun
    Lee, Dong Yun
    Cho, Sungpil
    Lee, Yong-Kyu
    NANO LETTERS, 2021, 21 (11) : 4666 - 4675
  • [38] Large-scale manufacturing of plasmid DNA for gene therapy and DNA vaccination - Part 1: The suitability of current techniques to purify plasmid without adding RNase
    Eon-Duval, A
    BIOPHARM INTERNATIONAL, 2003, 16 (08) : 48 - +
  • [39] Process development for the production of plasmid DNA by cultivation of E. coli in bioreactors.
    Chatrain, M
    Lee, C
    Kizer, L
    Listner, K
    Okonkowski, J
    Greasham, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U221 - U221
  • [40] Optimization and delivery of plasmid DNA for vaccination
    Jechlinger, Wolfgang
    EXPERT REVIEW OF VACCINES, 2006, 5 (06) : 803 - 825